long intergenic non-protein coding RNA 1497Genealiases: []
Q-omics provides the consensus-scored LINC01497 profile across patient tissues and cancer cell-line models. LINC01497 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in KICH. Among the 18 cancer types available for tumor–normal comparison, LINC01497 is differentially expressed in 11, with the highest sampling consensus in KIRC. Additionally, LINC01497 RNA expression shows 8,732 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight KICH, KIRC, and TGCT as cancer lineages where LINC01497 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01497 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01497 survival associations across molecular data types. LINC01497 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01497 RNA expression–survival associations across cancer types. High LINC01497 expression shows unfavorable associations in KICH, STAD, LUAD, COAD and SKCM, but favorable associations in BLCA. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify KICH as the clearest survival context for LINC01497 RNA expression.
This table summarizes LINC01497 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01497. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01497 shows lower tumor expression in KIRC, HNSC, THCA, STAD, BRCA and LUAD. The KIRC box plot shows higher LINC01497 RNA expression in normal versus tumor tissue (log2 FC = −0.246, t-test p < 0.001).
This table shows molecular features associated with LINC01497 in patient tissues and cancer cell lines. In patient samples, LINC01497 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
